Therapeutic management in ambulatory elderly patients with atrial fibrillation: The S.AGES cohort-Reference-Cited by-同舟云学术

Therapeutic management in ambulatory elderly patients with atrial fibrillation: The S.AGES cohort

Published:2015-01-10 Issue:2 Volume:19 Page:219-227
ISSN:1279-7707
Container-title:The journal of nutrition, health & aging
language:en
Short-container-title:J Nutr Health Aging

Author:

Hanon O., ,Vidal J. S.,Pisica-Donose G.,Benattar-Zibi L.,Bertin P.,Berrut G.,Corruble E.,Derumeaux G.,Falissard B.,Forette F.,Pasquier F.,Pinget M.,Ourabah R.,Becquemont L.,Danchin N.

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology,Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s12603-015-0444-9.pdf

Reference31 articles.

1. Heeringa J, van der Kuip DAM, Hofman A et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949–953.

2. Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e257–354.

3. Camm AJ, Kirchhof P, Lip GYH et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369–2429.

4. Camm AJ, Lip GYH, De Caterina R et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719–2747.

5. Singer DE, Chang Y, Fang MC et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med. 2009;151:297–305.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study;Drugs & Aging;2018-03-21

3. Real-Life Peak and Trough Dabigatran Plasma Measurements Over Time in Hospitalized Geriatric Patients with Atrial Fibrillation;The journal of nutrition, health & aging;2018-01

4. Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub‐Analysis From the PREFER in AF ( PRE vention o F Thromboembolic Events– E uropean R egistry in A trial F ibrillation);Journal of the American Heart Association;2017-07

5. Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF;International Journal of Cardiology;2017-04